# Limited Availability and Higher Cost of Gluten‐Free Foods Continue in the United Kingdom: A Comparative Follow‐Up Over More Than a Decade

**Authors:** Harrison McInnes, Lea Klapan, Umara Moore, Jaspreet Singh, Kevin Whelan

PMC · DOI: 10.1111/jhn.70209 · Journal of Human Nutrition and Dietetics · 2026-02-02

## TL;DR

Gluten-free foods in the UK remain limited in availability and more expensive than regular foods, even after over a decade of increased demand.

## Contribution

The study provides a longitudinal comparison of gluten-free food availability and cost in the UK over 11 years using consistent methodology.

## Key findings

- Only 7.6 gluten-free foods (out of 20 surveyed) were available on average per store in 2021.
- Regular supermarkets reduced gluten-free food availability from 90% in 2010 to 70% in 2021.
- Gluten-free foods remained more expensive, often exceeding inflation, though the price gap has narrowed.

## Abstract

Coeliac disease requires strict lifelong adherence to a gluten‐free diet, although adherence is challenged by the limited availability and higher cost of gluten‐free foods. The demand for gluten‐free foods has increased over recent years, yet its impact on availability and cost is unknown. This study aims to assess the availability and cost of gluten‐free food across diverse retail outlets and compare changes over 11 years.

Replicating the same methodology as our previous study in 2010, the availability and cost of 20 foods (10 wheat‐based, 10 everyday foods) were assessed in 30 stores across a diverse range of London boroughs and compared over an 11‐year period. For each of the 20 foods, the cost of four products were selected (branded gluten‐free, cheapest gluten‐free, branded standard, cheapest standard) and compared.

Availability of the 20 foods in 2021 was generally limited, with an average of 7.6 (SD 5.7) gluten‐free foods per store (38.2% of foods surveyed). Regular supermarkets in particular saw a reduction in availability over time from 18.0 (SD 2.0) of the 20 foods (90% of foods) available in gluten‐free versions in 2010 decreasing to 14.0 (SD 1.4, 70%) in 2021 (p = 0.008). Gluten‐free foods were more expensive than gluten‐containing counterparts. In terms of secular trends, the 2021 cost generally exceeded inflation‐adjusted estimates; however, the ratio between the cost of gluten‐free and gluten‐containing foods declined over the 11 years.

Over 11 years in the UK, gluten‐free food availability remained limited and more costly. Any impact of sustained limited availability and higher cost on adherence to a gluten‐free diet should be addressed and interventions to overcome these issues should be tested.

Gluten‐free foods are essential in the management of coeliac disease.On average, only 7.6 gluten‐free foods (out of 20 foods surveyed) were available in a range of stores in the UK, a situation that has not improved in over a decade.Regular supermarkets saw a reduction in the availability of gluten‐free foods during this time.Gluten‐free foods continue to be more expensive than their standard counterparts, often exceeding inflation, although the gap has declined over time.

Gluten‐free foods are essential in the management of coeliac disease.

On average, only 7.6 gluten‐free foods (out of 20 foods surveyed) were available in a range of stores in the UK, a situation that has not improved in over a decade.

Regular supermarkets saw a reduction in the availability of gluten‐free foods during this time.

Gluten‐free foods continue to be more expensive than their standard counterparts, often exceeding inflation, although the gap has declined over time.

## Full-text entities

- **Diseases:** intestinal inflammation (MESH:D007249), diarrhoea (MESH:D003967), fear (MESH:C000719212), anxiety (MESH:D001007), anorexia (MESH:D000855), irritable bowel syndrome (MESH:D043183), food insecurity (MESH:D005517), arthritis (MESH:D001168), Coeliac disease (MESH:D004194), weight loss (MESH:D015431), constipation (MESH:D003248), PCT (MESH:D017119), malabsorption (MESH:D008286), osteoporosis (MESH:D010024), villous atrophy (MESH:C564019), gut health (OMIM:603663), disordered eating patterns (MESH:D001068), anaemia (MESH:D000743), vomiting (MESH:D014839), gastrointestinal symptoms (MESH:D012817), mucosal damage (MESH:D052016), neurological, endocrinological, musculoskeletal, psychological, oral and dermatological disorders (MESH:D009140), autoimmune disorder (MESH:D001327)
- **Chemicals:** manganese (MESH:D008345), iodine (MESH:D007455), selenium (MESH:D012643), carbohydrate (MESH:D002241), volatile organic compounds (MESH:D055549), iron (MESH:D007501), zinc (MESH:D015032), FODMAP (-), calcium (MESH:D002118)
- **Species:** Homo sapiens (human, species) [taxon 9606], Gallus gallus (bantam, species) [taxon 9031]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12862883/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12862883/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12862883/full.md

---
Source: https://tomesphere.com/paper/PMC12862883